RVT-3101
Roche’s $7B Investment Ignites Intense Competition with Merck in the Bowel Disease Market Amid TL1A Feeding Frenzy
Anika Sharma
Roche has made a substantial move by agreeing to pay Roivant and Pfizer $7.1 billion upfront for regional rights to ...
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
SG Tylor
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
